Dmitry V. Shcheblyakov

This study compares circular and linear mRNA vectors, finding linear vectors have higher expression levels but equal immunogenicity and protective activity.

The paper assesses seroprevalence and cross-reactivity of neutralizing antibodies to six adenovirus types and suggests Ad1 or Ad2 as potential vaccine vector candidates.

This paper develops an mRNA platform for delivering single-domain antibodies, achieving 100% protection against high doses of botulinum neurotoxin A in mice.